Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
Muendlein A, Severgnini L, Decker T, Heinzle C, Leiherer A, Geiger K, Drexel H, Winder T, Reimann P, Mayer F, Nonnenbroich C, Dechow T.
Muendlein A, et al. Among authors: geiger k.
Front Oncol. 2022 Oct 24;12:1045995. doi: 10.3389/fonc.2022.1045995. eCollection 2022.
Front Oncol. 2022.
PMID: 36353562
Free PMC article.